insights_auto
Why is ONCY up २.३१%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
US$ ०.५६
arrow_upward
+२.३१%(+०.०१३) 1D
US$ ०.५५
arrow_downward
-१.२६% (-०.००७०)bedtimeAfter hours
Closed: अक्टोबर ९, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
US$ ०.५५
High
US$ ०.५७
Low
US$ ०.५२
Mkt. cap
७.३० करोड
Avg. vol.
१०.४६ लाख
Volume
१४.६१ लाख
52-wk high
US$ १.३२
52-wk low
US$ ०.५२
Beta
१.१५
Shares outstanding
१२.७५ करोड
No. of employees
२९
Open
US$ ०.५५
High
US$ ०.५७
Low
US$ ०.५२
Mkt. cap
७.३० करोड
Avg. vol.
१०.४६ लाख
Volume
१४.६१ लाख
52-wk high
US$ १.३२
52-wk low
US$ ०.५२
Beta
१.१५
Shares outstanding
१२.७५ करोड
No. of employees
२९
News stories
From web sources and news partners
https://www.dars.gov.et/
·
१ महिना पहिले
Oncolytics Biotech (ONCY) Holds Near $0.82 as Shares Edge Up 0.49% - Time Weighted Price
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc